Panacea Biotec L - Press Release - Facts Related to Pentaval...

The drug controller-general of India (DCG) has clarified that no permission has been given to Delhi-based Panacea Biotec to sell re-labelled vials of a pentavalent vaccine manufactured by the company across the country.

India 's government wants the country to become the world's preeminent low-cost vaccine supplier, but it will first have to overcome problems of its own making. A WHO embargo in the late 2000s slowed growth, and isolated quality problems have ...

Data for 800 companies from Bombay Stock Exchange. Values are: days closing price, previous closing price in brackets, 52-week low and high in bold, and volume traded (in 000) in brackets. GROUP A A A B B 545.55(521.55) 830-469 (23) A C C 1249.8(1229.65) ...

Drug inspectors seized at least 19,000 consignments of the pentavalent vaccine Easyfive TT' from a clearing and forwarding agency in Guindy on Monday. The agency that was raided is a sister concern of Delhi-based Panacea Biotec Limited Company.

Following the recall of one batch (P1062/SBP-A) of pentavalent vaccine, Easy Five TT, by the manufacturing company after Tamil Nadu drug control authorities seizure of 15063 relabelled vials and freezing of sales of the vaccine, the vaccine expert ...

Data for 800 companies from Bombay Stock Exchange. Values are: day's closing price, previous closing price in brackets, 52-week low and high in bold, and volume traded (in 000) in brackets. GROUP A A A B B 504.2(508.55) 830-469 (4) A C C 1254.65(1214.9) ...

NEW YORK, Jan. 30, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: ...

Though China suspects the virus could be spreading from humans since in 40 percent of the 80 plus cases of infection, there was no poultry contact. For all we know, the infection will be contained within some Chinese provinces and the fear of a ...

Rheumatoid Arthritis Pipeline Review, H1 2013 Summary Global Markets Direct's, ' ', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Rheumatoid Arthritis, complete ...